Aspire Biopharma Files 8-K: Equity Sales & Accountant Change
Ticker: ASBPW · Form: 8-K · Filed: Sep 26, 2025 · CIK: 1847345
Sentiment: neutral
Topics: unregistered-securities, accountant-change, corporate-actions
Related Tickers: ASBP
TL;DR
ASBP filed an 8-K on 9/22 reporting equity sales and accountant change. Check financials.
AI Summary
Aspire Biopharma Holdings, Inc. filed an 8-K on September 26, 2025, reporting on unregistered sales of equity securities and changes in its certifying accountant. The filing also includes financial statements and exhibits. The company was formerly known as PowerUp Acquisition Corp.
Why It Matters
This filing provides updates on the company's financial activities and auditor status, which are crucial for investors to assess the company's financial health and governance.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities, which can sometimes indicate financial distress or dilution concerns for existing shareholders.
Key Players & Entities
- Aspire Biopharma Holdings, Inc. (company) — Registrant
- PowerUp Acquisition Corp. (company) — Former Company Name
- September 22, 2025 (date) — Date of earliest event reported
- September 26, 2025 (date) — Date of Report
FAQ
What specific type of equity securities were sold unregistered?
The filing indicates 'Unregistered Sales of Equity Securities' as an item, but does not specify the type or amount in the provided text.
Who is the new certifying accountant for Aspire Biopharma Holdings, Inc.?
The filing lists 'Changes in Registrant's Certifying Accountant' as an item, but the name of the new accountant is not provided in the excerpt.
When did Aspire Biopharma Holdings, Inc. change its name from PowerUp Acquisition Corp.?
The filing indicates a name change from PowerUp Acquisition Corp. on February 22, 2021.
What is the SIC code for Aspire Biopharma Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Aspire Biopharma Holdings, Inc. is 2834, Pharmaceutical Preparations.
What is the state of incorporation for Aspire Biopharma Holdings, Inc.?
Aspire Biopharma Holdings, Inc. is incorporated in Delaware.
Filing Stats: 1,087 words · 4 min read · ~4 pages · Grade level 17.5 · Accepted 2025-09-26 17:10:30
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ASBP The Nasdaq Stock Mar
- $9,687,500 — tes in an aggregate principal amount of $9,687,500 for a subscription price of $7,750,000.
- $7,750,000 — $9,687,500 for a subscription price of $7,750,000. Of the $7,750,000 total funding under
- $4,709,677 — l funding under the Purchase Agreement, $4,709,677 was funded on August 19, 2025. The seco
- $1,000,000 — September 22, 2025 for an aggregate of $1,000,000. Item 4.01 Changes in Registrant's Ce
Filing Documents
- form8-k.htm (8-K) — 49KB
- 0001493152-25-015773.txt ( ) — 258KB
- asbp-20250922.xsd (EX-101.SCH) — 4KB
- asbp-20250922_def.xml (EX-101.DEF) — 26KB
- asbp-20250922_lab.xml (EX-101.LAB) — 36KB
- asbp-20250922_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASPIRE BIOPHARMA HOLDINGS, INC. Dated: September 26, 2024 By: /s/ Kraig Higginson Kraig Higginson Chief Executive Officer